Cardiovascular Cell: Types, Functions, and Disease

The heart and blood vessels are built from a surprisingly diverse collection of specialized cells, each with a distinct job that keeps blood moving and tissues alive. Cardiomyocytes generate the force behind every heartbeat, endothelial cells line every vessel and regulate what passes through, smooth muscle cells control vessel diameter, fibroblasts maintain the structural scaffold, and immune cells patrol for damage. When any of these cell populations malfunction, the consequences range from stiffened arteries and irregular rhythms to heart failure and heart attack. Understanding what each cell type does, and how it breaks down, is central to modern cardiology.

Cardiomyocytes and the Mechanics of Every Heartbeat

Cardiomyocytes are the muscle cells that contract in unison to pump blood. They make up the bulk of the heart’s mass, though they are actually outnumbered by other cell types. Their defining trick is excitation-contraction coupling: an electrical signal arrives, calcium floods into the cell, and the cell shortens. Much of that calcium comes from an internal storage compartment called the sarcoplasmic reticulum, released through a process where a small initial burst of calcium triggers a much larger release from the stores.

1PubMed Central. Calcium and Excitation-Contraction Coupling in the Heart

For this system to work beat after beat, every calcium ion that enters the cell during contraction must eventually be pumped back out or reloaded into storage. If that balance breaks down, calcium accumulates where it should not, and the cell contracts poorly or erratically. Disrupted calcium handling is a hallmark of heart failure, where the heart progressively loses its ability to pump enough blood.

2PubMed Central. New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 3Progress in Biophysics and Molecular Biology. Cardiomyocyte calcium handling in health and disease: Insights from in vitro and in silico studies

Cardiomyocytes are also unusual among muscle cells because adult human heart cells barely divide. Lose a patch of them to a heart attack and the body replaces them mostly with scar tissue rather than new muscle. That limited regenerative capacity is a major reason heart attacks cause lasting damage, and it is the motivation behind a large body of research on stem cell-based repair strategies.

Endothelial Cells and the Vessel Lining

Every blood vessel, from the aorta to the tiniest capillary, is lined with a single layer of endothelial cells. These cells do far more than act as passive wallpaper. They produce nitric oxide, a signaling molecule that relaxes the smooth muscle in vessel walls and keeps blood flowing smoothly.

4PubMed. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo Nitric oxide also discourages blood platelets from clumping and white blood cells from sticking to the vessel wall, so a healthy endothelium is essentially anti-inflammatory and anti-clotting at the same time.

When endothelial cells are stressed by high blood pressure, high blood sugar, smoking, or oxidized cholesterol particles, they start losing their protective functions. They produce less nitric oxide and begin displaying adhesion molecules on their surface, essentially rolling out a welcome mat for immune cells. One of these adhesion molecules, VCAM-1, appears early in the development of atherosclerosis, marking spots where fatty plaques will eventually grow.

5PubMed. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis

Endothelial cells also talk constantly to the cardiomyocytes beside them. The two cell types exchange paracrine signals, chemical messages secreted into the surrounding space, that regulate heart muscle growth, blood vessel formation, and how hard the muscle contracts. Endothelial cells release factors that influence whether cardiomyocytes grow in a healthy or an abnormal way, while cardiomyocytes send signals back that guide the formation of new blood vessels.

6PubMed. Endothelial cell-cardiomyocyte cross-talk: understanding bidirectional paracrine signaling in cardiovascular homeostasis and disease 7PubMed Central. Endothelial cell-cardiomyocyte crosstalk in heart development and disease

Vascular Smooth Muscle Cells and Their Shape-Shifting Problem

Wrapped around blood vessels in concentric layers, vascular smooth muscle cells control vessel diameter. When they contract, arteries narrow and blood pressure rises; when they relax, vessels widen. But these cells have a remarkable second life. They are not locked into a single identity the way most mature cells are. Instead, they can switch between a contractile state, where they do their squeezing job, and a synthetic state, where they start multiplying, migrating, and producing structural proteins.

8PubMed Central. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity

This shape-shifting is useful during wound healing and vessel growth, but it becomes dangerous when it feeds disease. In atherosclerosis, smooth muscle cells that switch to the synthetic state migrate into the vessel wall, accumulate cholesterol, and become foam cells, the lipid-stuffed cells that build up fatty plaques. Work in both human tissue and mouse models has shown that smooth muscle cells contribute a surprisingly large share of foam cells in plaques. In advanced human coronary disease, roughly half of all foam cells in lesions turned out to be smooth muscle cell-derived rather than coming from immune cells, as had long been assumed.

9PubMed. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis 10PubMed Central. Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis

Part of the reason these cells accumulate so much cholesterol is that they express lower levels of a transporter protein that normally helps cells offload excess cholesterol. That finding has led researchers to view smooth muscle cell foam cells as a separate therapeutic target, distinct from the macrophage-focused strategies that have dominated atherosclerosis research for decades.

9PubMed. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis

Lineage-tracing studies have added another layer of complexity: only a small number of mature smooth muscle cells actually dedifferentiate, but those few give rise to large populations of lesion cells, creating what researchers describe as oligoclonal patches within plaques. Single-cell gene profiling of diseased vessels has revealed a striking diversity of phenotypes arising from those few founding cells.

11JVS-Vascular Science. Targeting smooth muscle cell phenotypic switching in vascular disease

Cardiac Fibroblasts and the Scar That Stiffens the Heart

Fibroblasts are the primary producers of the heart’s extracellular matrix, the protein scaffold that holds everything together and transmits mechanical forces between beating cells.

12PubMed Central. Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease In a healthy heart, fibroblasts quietly maintain this scaffold, participate in signaling, and keep the tissue flexible. After an injury like a heart attack, though, immune cells and fibroblasts drive an inflammatory wound-healing response that replaces dead muscle with fibrotic scar tissue.

13PubMed Central. Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair

The molecular driver behind excessive scarring is a growth factor called TGF-beta. It activates fibroblasts and pushes them to differentiate into myofibroblasts, which are essentially fibroblasts on overdrive: they produce far more matrix proteins and contract, pulling surrounding tissue tighter.

14PubMed Central. Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players Studies in mouse models have shown that when the signaling pathway downstream of TGF-beta is disabled specifically in fibroblasts, the fibrotic response to pressure overload drops markedly.

15JCI Insight. Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis

What makes this clinically relevant is that fibrosis stiffens the heart wall, making it harder for the chambers to fill with blood between beats. Over time, that stiffness can lead to heart failure even when the heart’s squeezing power is preserved, a condition sometimes called heart failure with preserved ejection fraction. TGF-beta signaling appears to dominate the fibrotic process even when the tissue environment is already stiff, suggesting that blocking TGF-beta pathways could reduce scarring regardless of how far the disease has progressed.

16PubMed Central. TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts

Pacemaker Cells, Macrophages, and Pericytes

Not every important cardiac cell fits neatly into the big categories above. The heart’s rhythm originates in a cluster of specialized pacemaker cells in the sinus node. These cells fire spontaneously, without needing an external signal, because they carry a unique set of ion channels that cause their voltage to drift upward until it triggers an action potential. Human pacemaker cells differ from the rabbit cells studied for decades: human cells have a much smaller “funny current,” the ion flow responsible for that slow voltage drift, though the current still plays a similar regulatory role.

17PubMed Central. Computational analysis of the human sinus node action potential: model development and effects of mutations

Resident macrophages, a type of immune cell that lives permanently in heart tissue, have turned out to have surprisingly broad roles. Beyond their classic job of clearing debris and dead cells, cardiac macrophages promote the growth of new blood vessels and even facilitate electrical conduction through the heart.

18PubMed Central. The Macrophage in Cardiac Homeostasis and Disease – Section: Cardiac Macrophages Functions 19PubMed. Cardiac resident macrophages in cardiovascular disease: from physiology to pathology That last finding was unexpected: macrophages physically couple to conduction-system cells and help electrical impulses pass through the atrioventricular node. After a heart attack, though, the population of resident macrophages shifts, and the replacement cells tend to be more inflammatory and less helpful for repair.

20PubMed Central. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction

Pericytes, small cells that wrap around the outside of capillaries, regulate local blood flow at the smallest scale. They contract and relax to adjust the diameter of capillaries, directing blood to areas of the heart muscle that need more oxygen at any given moment.

21PubMed Central. Pericytes and the Control of Blood Flow in Brain and Heart

What Happens When Blood Flow Returns After a Heart Attack

One of the cruelest paradoxes in cardiology is that restoring blood flow to heart muscle after a blockage can itself cause additional damage, a phenomenon known as ischemia-reperfusion injury. During the period without blood flow, the cell’s energy supply collapses and calcium builds up inside cells because the pumps that normally keep calcium levels low cannot function without fuel. When blood flow resumes, oxygen re-enters, but the damaged energy-producing machinery in the mitochondria generates a burst of harmful reactive oxygen species instead of efficiently making energy.

22PubMed Central. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury

The combination of calcium overload and reactive oxygen species triggers the opening of a pore in the mitochondrial membrane. Once that pore opens, the mitochondria lose their ability to produce energy altogether, swell with incoming water, and the cell’s membrane eventually ruptures.

23JCI Insight. Mechanisms of postischemic cardiac death and protection following myocardial injury – Section: Cell-death pathways Multiple forms of cell death are at play, including pathways that were once thought to be entirely unregulated but are now known to be controlled by specific molecular switches. These include regulated necrosis, ferroptosis (an iron-dependent form of cell death), and pyroptosis, all of which interact with and amplify each other.

24PubMed Central. Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management

How Chemotherapy Damages the Heart

The overlap between oncology and cardiology has become its own subspecialty because several widely used cancer drugs are directly toxic to cardiovascular cells. Anthracyclines, a class that includes doxorubicin, cause irreversible, dose-dependent damage to the heart muscle through oxidative stress, disruption of mitochondrial function, and interference with an enzyme that manages DNA repair in cardiomyocytes.

25PubMed Central. Chemotherapy-Induced Cardiotoxicity: Mechanisms, Detection and Emerging Therapies in Cardio-Oncology

The mechanism shares some features with ischemia-reperfusion injury but has its own distinct biology. Doxorubicin can bind directly to the nitric oxide-producing enzyme in endothelial cells, causing it to malfunction and generate damaging oxygen radicals instead of the protective nitric oxide the vessel lining depends on.

26Frontiers in Cardiovascular Medicine. NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity – Section: The impact of chemotherapeutic agents on the cardiovascular NO/NOS system Meanwhile, inside cardiomyocytes, the drug intercalates with DNA and triggers a cascade that leads to mitochondrial membrane collapse, activation of cell-death pathways, and eventually fibrotic remodeling of the surviving tissue.

27Frontiers in Cardiovascular Medicine. Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications – Section: Anthracyclines

Targeted therapies are not immune to these problems either. Trastuzumab, used against certain breast cancers, blocks a receptor that cardiomyocytes rely on for survival signaling. Without that signal, oxidative stress rises and nitric oxide production falls, leading to cardiomyocyte death.

26Frontiers in Cardiovascular Medicine. NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity – Section: The impact of chemotherapeutic agents on the cardiovascular NO/NOS system

Mapping the Heart Cell by Cell

Until recently, much of what we knew about cardiac cell types came from staining thin slices of tissue and looking at them under a microscope. Single-cell and single-nucleus sequencing have changed the picture dramatically. A large-scale atlas of the adult human heart profiled six anatomical regions and revealed previously unappreciated diversity: cardiomyocytes, pericytes, and fibroblasts all showed distinct subtypes depending on whether they sat in an atrium or a ventricle, with different developmental origins and specialized gene-expression profiles.

28Nature. Cells of the adult human heart

A separate effort sequencing nearly 290,000 cardiac nuclei identified nine major cell types and twenty subclusters, including two distinct populations of resident macrophages, four endothelial subtypes, and two fibroblast subsets.

29PubMed Central. Transcriptional and Cellular Diversity of the Human Heart More recently, an integrated atlas called HeartMap pooled data from nine studies, encompassing over 2.4 million nuclei from 209 individuals, across healthy hearts and seven disease states.

30Nature Cardiovascular Research. An integrated cell atlas of 2.4 million cardiac cells across 209 individuals in health and disease

These datasets are already reshaping how researchers think about disease. By comparing gene expression in healthy and failing hearts at the single-cell level, scientists can pinpoint which cell subtypes change their behavior in disease, which genes switch on or off, and which cell-cell communication pathways go awry. It is the kind of resolution that was simply impossible a decade ago, and it is beginning to reveal drug targets that would never have been spotted by looking at heart tissue in bulk.

Regeneration and Progenitor Cells

Because adult cardiomyocytes barely divide, regenerating heart muscle after damage has been a long-standing goal. One approach uses induced pluripotent stem cells, adult cells reprogrammed back to an embryonic-like state and then coaxed into becoming cardiomyocytes. In animal studies, transplanting these lab-grown heart cells into infarcted rat hearts restored heart function and reversed harmful remodeling of the ventricle within four weeks.

31PubMed Central. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts

Combining cell types appears to help. A study transplanting stem cell-derived cardiomyocytes alongside endothelial cells into infarcted mouse and primate hearts achieved remuscularization of the damaged area.

32PubMed Central. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates Another group used a 3D-bioprinted cardiac patch made from stem cell-derived cells and showed that animals receiving the patch had roughly half the scar area and double the blood vessel count compared with controls.

33PubMed Central. Cardiac Regeneration Using Human iPSC-derived Biomaterial-free 3D bioprinted Cardiac Patch in vivo

On the vascular side, the body maintains a small pool of endothelial progenitor cells in the bone marrow that can mobilize into the bloodstream, home to injured or oxygen-starved tissues, and differentiate into mature endothelial cells.

34PubMed. Endothelial progenitor cells: mobilization, differentiation, and homing This process mirrors what happens during embryonic development, when new blood vessels form from scratch rather than simply branching from existing ones.

35Cardiovascular Research. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration Endothelial colony-forming cells, a subset of these progenitors, have shown promise in animal models of impaired blood flow, raising interest in them as a potential cell source for patients with vascular disease.

36PubMed Central. Endothelial colony-forming cell role in neoangiogenesis and tissue repair

When Cells Feel the Squeeze

Heart cells live under constant mechanical stress. Every beat stretches and compresses them. That mechanical load is not just a physical burden; cells actively sense it and convert it into chemical signals that alter their structure and gene expression, a process called mechanotransduction. In cardiomyocytes, protein complexes at the sarcomere, the intercalated disc where cells join end to end, and the outer membrane all serve as load sensors.

37PubMed Central. Mechanotransduction in cardiac hypertrophy and failure

When the heart faces chronically elevated pressure, such as from uncontrolled high blood pressure or a narrowed aortic valve, mechanotransduction signals push cardiomyocytes to thicken their walls in a process called hypertrophy. Initially this is compensatory, but over time the signaling becomes maladaptive, contributing to stiffness, arrhythmia, and eventual failure. Genetic studies in humans and mice have identified several cytoskeletal and membrane proteins as the likely culprits linking mechanical load to disease-causing signaling cascades.

Metabolic Shifts in the Failing Heart

A healthy adult heart is a voracious consumer of fatty acids, burning them for the bulk of its energy. In heart failure, the metabolic machinery shifts. The heart starts relying more on glucose and less on fat, and overall energy production drops.

38PubMed Central. Targeting myocardial substrate metabolism in heart failure: potential for new therapies This is sometimes described as a return to a more fetal-like metabolic profile, because the developing heart also preferentially uses glucose.

The metabolic shift is not just a symptom; it feeds the disease. Lower energy output means the heart cannot contract as forcefully, and byproducts of altered metabolism can themselves push cells toward harmful states. Lactate, for example, which accumulates when tissue is oxygen-starved, has been shown to push vascular smooth muscle cells toward a synthetic phenotype, increasing their tendency to proliferate and migrate rather than contract.

39PubMed Central. Lactate Promotes Synthetic Phenotype in Vascular Smooth Muscle Cells Researchers are exploring whether drugs that nudge the heart’s fuel preference back toward fatty acid oxidation, or that improve the efficiency of glucose use, could slow the progression of heart failure. The field has also increasingly recognized that non-coding RNA molecules, stretches of genetic material that do not encode proteins but regulate gene activity, play roles in controlling these metabolic and structural changes across multiple cardiovascular diseases.

40PubMed Central. The Role of Long Non-Coding RNAs in Cardiovascular Diseases